MRF Hosts Meeting to Find New Treatments for Melanoma

Fri, 2010-06-18

The Melanoma Research Foundation hosted a meeting on June 7 to coincide with the American Society of Clinical Oncology’s (ASCO) annual meeting in Chicago to discuss the MRF Breakthrough Consortium. Attendees included leading melanoma researchers and members of the MRF’s board of directors. The MRF Breakthrough Consortium is a collaborative effort between researchers, pharmaceutical companies and the government to accelerate the discovery of combination therapies for melanoma.

Lynn Schuchter, M.D., recently wrote an article for CNBC about melanoma research updates presented at ASCO and included the MRF Breakthrough Consortium as a platform to hasten research  

MRF Breakthrough Consortium 

Attendees at the meeting involved in the Consortium included:

Front row from left to right: Antoni Ribas, M.D., University of California, Los Angeles; F. Stephen Hodi, M.D., Dana Farber Cancer Institute; Jedd D. Wolchok, M.D., Ph.D., Memorial Sloan Kettering Cancer Center; Patrick Hwu, M.D., Anderson Cancer Center; Lynn Schuchter, M.D., Abramson Cancer Center, University of Pennsylvania; Larry Hunt, Melanoma Research Foundation; Jeffrey A. Sossman, M.D., Vanderbilt University; John M. Kirkwood, M.D., University of Pittsburgh Cancer Institute; Kevin Kim, M.D., MD Anderson Cancer Center

Back row from left to right: Stergios Moschos, M.D., University of Pittsburgh; Kate Nathanson, M.D., University of Pennsylvania; Martin McMahon, Ph.D., University of California San Francisco; Jeffrey E. Gershenwald, M.D., MD Anderson Cancer Center; Mario Sznol, M.D., Yale University; Igor Puzanov, M.D., Vanderbilt University; Keith T. Flaherty, M.D., Massachusetts General Hospital Cancer Center; Meenhard Herlyn, D.V.M., D.Sc., Wistar Institute Cancer Center; C. Randy Lomax, Melanoma Research Foundation; Michael B. Atkins, M.D., Beth Israel Deaconess Medical Center; Tim Turnham, Ph.D., Melanoma Research Foundation; Rajeev Agarwal, M.D., National Cancer Institute; Alison Martin, M.D., Melanoma Research Foundation; Jeffrey S. Weber, M.D., Ph.D., Moffitt Cancer Center; Robin Burns, Melanoma Research Foundation